Explore All Access
Check if your research matches the topics covered in Drugs in R and D?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drugs in R and D : Impact Factor & More
eISSN: 1179-6901pISSN: 1174-5886
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Drugs in R and D Key Metrics
CiteScore 
4.3
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.95
Topics Covered on Drugs in R and D
Intravenous therapy
Mode of action
Docetaxel
Clinical trial
Steady state
Skeletal muscle
Toxicity
N-Acetylmannosamine
Hereditary angioedema
Fentanyl
Infliximab
Particle size
Cardiopulmonary bypass
Intensive care unit
Confidence interval
CYP2C19
Antitumor activity
Randomized controlled trial
Respiratory epithelium
Oral administration
Drugs in R and D Journal Specifications
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 2690 | USD 3390 | GBP 2290 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Drugs in R and D ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs in R and D
Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers.
- 21 Oct 2024
- Drugs in R&D
Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants.
- 5 Oct 2024
- Drugs in R&D
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers.
- 24 Sep 2024
- Drugs in R&D
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia.
- 24 Sep 2024
- Drugs in R&D
A Case Report of JAK Inhibitors Therapy for Adult-Onset Still's Disease with Persistent Pruritic Lesions.
- 18 Sep 2024
- Drugs in R&D
Changes in Early-Phase Clinical Trials in China During 2013-2022: A Review.
- 12 Sep 2024
- Drugs in R&D
Pharmacokinetics and Bioequivalence of Two Powders of Azithromycin for Suspension: A Nonblinded, Single-Dose, Randomized, Three-Way Crossover Study in Fed and Fasting States Among Healthy Chinese Volunteers.
- 21 Oct 2024
- Drugs in R&D
Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants.
- 5 Oct 2024
- Drugs in R&D
Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug-Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers.
- 24 Sep 2024
- Drugs in R&D
Trametinib Sensitivity is Defined by a Myeloid Differentiation Profile in Acute Myeloid Leukemia.
- 24 Sep 2024
- Drugs in R&D
A Case Report of JAK Inhibitors Therapy for Adult-Onset Still's Disease with Persistent Pruritic Lesions.
- 18 Sep 2024
- Drugs in R&D
Changes in Early-Phase Clinical Trials in China During 2013-2022: A Review.
- 12 Sep 2024
- Drugs in R&D
Compare Similar Journals with Drugs in R and D
Select Journals to Compare with Drugs in R and D
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Scientific Reports
Publisher: NATURE PORTFOLIO
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
British Journal of Clinical Pharmacology
Publisher: WILEY
Cancer Chemotherapy and Pharmacology
Publisher: SPRINGER
Annals of Oncology
Publisher: ELSEVIER
Journal of Clinical Pharmacology
Publisher: WILEY
Journal of Clinical Medicine
Publisher: MDPI
0 Journals Selected to compare with
Drugs in R and D
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drugs in R and D
How long has Drugs in R and D been actively publishing? 
Drugs in R and D has been in operation since 1999 till date.
What is the publishing frequency of Drugs in R and D?
Drugs in R and D published with a Quarterly frequency.
How many articles did Drugs in R and D publish last year?
In 2023, Drugs in R and D publsihed 38 articles.
What is the eISSN & pISSN for Drugs in R and D?
For Drugs in R and D, eISSN is 1179-6901 and pISSN is 1174-5886.
What is Citescore for Drugs in R and D?
Citescore for Drugs in R and D is 4.3.
What is SNIP score for Drugs in R and D?
SNIP score for Drugs in R and D is 0.95.
What is the SJR for Drugs in R and D?
SJR for Drugs in R and D is Q2.
Who is the publisher of Drugs in R and D?
SPRINGER INT PUBL AG is the publisher of Drugs in R and D.
